Steroid-Responsive Retroperitoneal Fibrosis and Sclerosing Mesenteritis as the Initial Manifestation of an Occult Neuroendocrine Tumor

Retroperitoneal fibrosis (RPF) and sclerosing mesenteritis (SM) are rare entities characterized by fibrous inflammatory tissue that can surround and compress adjacent abdominal structures, leading to organ damage. RPF and SM have rarely been reported to present simultaneously. Idiopathic forms of RPF and SM are typically treated with immunosuppression, whereas treatment of RPF and SM secondary to malignancy relies on treating the underlying malignancy. We present a patient with steroid-responsive RPF and SM ultimately found to be secondary to an occult small intestinal neuroendocrine tumor who responded to octreotide therapy for the underlying neuroendocrine tumor.

Authors

Institutions

Publication Details

Journal
Annals of Internal Medicine Clinical Cases
Published
2025-04-01
DOI
https://doi.org/10.7326/aimcc.2025.0039
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Steroid-Responsive Retroperitoneal Fibrosis and Sclerosing Mesenteritis as the Initial Manifestation of an Occult Neuroendocrine Tumor

Lap-Heng Keung, Elliot D. Rosenstein, Neil Kramer, Oksana M. Albayati
Annals of Internal Medicine Clinical Cases
Neuroendocrine Tumor Research Advances
article

Steroid-Responsive Retroperitoneal Fibrosis and Sclerosing Mesenteritis as the Initial Manifestation of an Occult Neuroendocrine Tumor

Lap-Heng Keung, Elliot D. Rosenstein, Neil Kramer, Oksana M. Albayati
article en

Abstract

Retroperitoneal fibrosis (RPF) and sclerosing mesenteritis (SM) are rare entities characterized by fibrous inflammatory tissue that can surround and compress adjacent abdominal structures, leading to organ damage. RPF and SM have rarely been reported to present simultaneously. Idiopathic forms of RPF and SM are typically treated with immunosuppression, whereas treatment of RPF and SM secondary to malignancy relies on treating the underlying malignancy. We present a patient with steroid-responsive RPF and SM ultimately found to be secondary to an occult small intestinal neuroendocrine tumor who responded to octreotide therapy for the underlying neuroendocrine tumor.

Annals of Internal Medicine Clinical CasesVol. 4(4)
Overlook Medical Center (US), Morristown Medical Center (US), Atlantic Health System (US)
Good health and well-being
Openalex Percentile: Top 89%
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Steroid-Responsive Retroperitoneal Fibrosis and Sclerosing Mesenteritis as the Initial Manifestation of an Occult Neuroendocrine Tumor — Lap-Heng Keung, Elliot D. Rosenstein, et al. · Annals of Internal Medicine Clinical Cases (2025) | TGRS Research Map | TGRS